Side-by-side financials for FENC and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FENC | BNTX |
|---|---|---|
| Market cap | - | $22.90 B |
| US-listed rank | - | #572 |
| Revenue (latest FY) | $44.64M | - |
| Net income (latest FY) | -$9.74B | - |
| Net margin | -21820.3% | - |
| SEC filings | 792 | 548 |
Full pages: FENNEC PHARMACEUTICALS INC. and BioNTech SE, or browse the full rankings.